Document Detail


FibroSURE and FibroScan in relation to treatment response in chronic hepatitis C virus.
MedLine Citation:
PMID:  22147963     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
AIM: To compare histological endpoint assessment using noninvasive alternatives to biopsy during treatment in a chronic hepatitis C virus (HCV) cohort.
METHODS: Patients with chronic HCV were randomized to receive interferon-based therapy for 24 (genotypes 2/3) or 48 (genotype 1) wk. FibroSURE™ (FS) was assessed at baseline and at week-12 post-treatment follow-up. Baseline biopsy for METAVIR was assessed by a single pathologist. FibroScan(®) transient elastography (TE) was performed during treatment in a patient subset.
RESULTS: Two thousand and sixty patients (n = 253 in Asia) were classified as METAVIR F0-1 (n = 1682) or F2-4 (n = 378). For F2-4, FS (n = 2055) had sensitivity and specificity of 0.87 and 0.61, respectively, with area under the receiver-operating curve of 0.82; corresponding values for TE (n = 214) and combined FS/TE (n = 209) were 0.77, 0.88 and 0.88, and 0.93, 0.68 and 0.88. Overall FS/TE agreement for F2-4 was 71% (κ = 0.41) and higher in Asians vs non-Asians (κ = 0.86 vs 0.35; P < 0.001). Combined FS/TE had 97% accuracy in Asians (n = 33). Baseline FS (0.38 vs 0.51, P < 0.001) and TE (8.0 kPa vs 11.9 kPa, P = 0.006) scores were lower in patients with sustained virological response than in nonresponders, and were maintained through follow-up.
CONCLUSION: FS and TE may reliably differentiate mild from moderate-advanced disease, with a potential for high diagnostic accuracy in Asians with chronic HCV.
Authors:
Keyur Patel; Mireen Friedrich-Rust; Yoav Lurie; Mircea Grigorescu; Carol Stanciu; Chuan-Mo Lee; Eugene R Schiff; Dieter Häussinger; Michael P Manns; Guido Gerken; Isabelle Colle; Michael Torbenson; Erik Pulkstenis; G Mani Subramanian; John G McHutchison; Stefan Zeuzem
Related Documents :
15645953 - Frequency and role of hepatitis-c virus and type ii cryoglobulinemia in membranoprolife...
10534353 - The impact of diagnosis of hepatitis c virus on quality of life.
9104733 - Elevated serum levels of cyclo (his-pro), an endogenous inhibitor of pituitary prolacti...
Publication Detail:
Type:  Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  World journal of gastroenterology : WJG     Volume:  17     ISSN:  1007-9327     ISO Abbreviation:  World J. Gastroenterol.     Publication Date:  2011 Nov 
Date Detail:
Created Date:  2011-12-07     Completed Date:  2012-02-08     Revised Date:  2013-05-22    
Medline Journal Info:
Nlm Unique ID:  100883448     Medline TA:  World J Gastroenterol     Country:  China    
Other Details:
Languages:  eng     Pagination:  4581-9     Citation Subset:  IM    
Affiliation:
Department of Gastroenterology and Hepatology, Duke Clinical Research Institute, Durham, NC 27715, United States. keyur.patel@duke.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Antiviral Agents / therapeutic use*
Asian Continental Ancestry Group
Biopsy
Cohort Studies
Elasticity Imaging Techniques / methods*
Female
Fibrosis
Hepacivirus / genetics,  metabolism*
Hepatitis C, Chronic / drug therapy*,  genetics,  pathology*,  physiopathology*
Humans
Interferons / therapeutic use*
Liver / pathology
Male
Middle Aged
Prospective Studies
ROC Curve
Chemical
Reg. No./Substance:
0/Antiviral Agents; 9008-11-1/Interferons
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Effects of cyclooxygenase-2 on human esophageal squamous cell carcinoma.
Next Document:  Evaluation of Fujinon intelligent chromo endoscopy-assisted capsule endoscopy in patients with obscu...